Chicken pox Vaccines
The varicella vaccine is given for immunization against chicken pox which is a very common, contagious and fatal disease among children as it may cause serious complications. A booster shot is administered for children at 4 to 6 years of age. It is 85% effective in preventing mild illness and has a less chance of an allergic reaction with any vaccine. Getting vaccinated is the best way to prevent chickenpox.
Related Conference of Chicken pox Vaccines
March 10-11, 2021
4th International Conference on Vaccines, Immunization and Clinical Trials
Amsterdam, Netherlands
Chicken pox Vaccines Conference Speakers
Recommended Sessions
- Allergy & Asthma Vaccines
- Antibodies Research
- Aquaculture Vaccines
- Chicken pox Vaccines
- Clinical Immunology & Immunopathology
- Flu Vaccines
- HIV Vaccines
- HPV Vaccines
- Immune System Disorders
- Immunization Challenges
- Immunology
- Infectious and Non infectious diseases Vaccines
- Onco Immunology
- Paediatric Immunology
- Paediatric Vaccines
- Plant Vaccines & Veterinary Vaccines
- Recombinant Vaccines
- Stem Cell Immunology
- Therapeutic Cancer Vaccines
- Transplant Immunology
- Travel & Edible Vaccinations
- Vaccine Induced Immunity
- Vaccine Types
- Vaccines
- Vaccines and Immunology Advancements
- Vaccines Efficacy and Safety
- Zika Virus Vaccines
Related Journals
Are you interested in
- Animal Models and Biological Research - Vaccines R&D 2021 (Netherlands)
- Bioinformatics and Biotherapeutics - Vaccines R&D 2021 (Netherlands)
- Biomarkers and Case Reports - Vaccines R&D 2021 (Netherlands)
- Cancer Vaccines and Immunotherapy - Euro Vaccines 2021 (Spain)
- Cancer, Malaria & TB Vaccines - Vaccines World 2021 (France)
- Childhood Vaccines and Maternal Vaccines - Euro Vaccines 2021 (Spain)
- Clinical Trials, Research and Development - Vaccines R&D 2021 (Netherlands)
- Combination & Conjugate Vaccines - Vaccines World 2021 (France)
- Coronavirus (Covid 19) and Next Generation Vaccines - Vaccines R&D 2021 (Netherlands)
- COVID-19 Vaccine Research & Development - Euro Vaccines 2021 (Spain)
- DNA & Synthetic Vaccines - Vaccines World 2021 (France)
- DNA Vaccines - Euro Vaccines 2021 (Spain)
- Emerging and Infectious Diseases - Vaccines R&D 2021 (Netherlands)
- Hepatitis Vaccines - Euro Vaccines 2021 (Spain)
- HIV Vaccines - Vaccines World 2021 (France)
- HIV Vaccines and Policy Issues - Vaccines R&D 2021 (Netherlands)
- HIV/AIDS Vaccines - Euro Vaccines 2021 (Spain)
- Human Preventive & Therapeutic Vaccines - Euro Vaccines 2021 (Spain)
- Human Vaccines - Infectious & Non Infectious Diseases - Euro Vaccines 2021 (Spain)
- Immunization and Bioprocessing - Vaccines R&D 2021 (Netherlands)
- Immuno-Oncology and Immunotherapy - Vaccines R&D 2021 (Netherlands)
- Immunology/Animal Models - Euro Vaccines 2021 (Spain)
- Influenza and Respiratory Vaccines - Vaccines R&D 2021 (Netherlands)
- Live Attenuated and Inactivated Vaccines - Vaccines R&D 2021 (Netherlands)
- Manufacturing, Production, and Delivery Technologies - Vaccines R&D 2021 (Netherlands)
- Mucosal Vaccines - Euro Vaccines 2021 (Spain)
- New Trends in Vaccines Development - Vaccines World 2021 (France)
- Next-Generation Vaccine Delivery Technologies - Euro Vaccines 2021 (Spain)
- Pediatric Vaccination - Vaccines World 2021 (France)
- Pediatric Vaccines - Vaccines World 2021 (France)
- Public Health and Patient Safety - Vaccines R&D 2021 (Netherlands)
- RDT in Antibiotic Research - Vaccines World 2021 (France)
- Regulatory Licensing and Scientific Affairs - Vaccines R&D 2021 (Netherlands)
- Side-effects of Vaccines - Vaccines World 2021 (France)
- Subunit/Conjugate and Toxoid Vaccines - Vaccines R&D 2021 (Netherlands)
- Toxoid Vaccines - Vaccines World 2021 (France)
- Translational Research on Pandemic Outbreaks - Vaccines R&D 2021 (Netherlands)
- Vaccine Adjuvants - Euro Vaccines 2021 (Spain)
- Vaccine Adjuvants and Antibody Engineering - Vaccines R&D 2021 (Netherlands)
- Vaccine Hesitancy and Health Literacy - Vaccines R&D 2021 (Netherlands)
- Vaccine Production & Development - Vaccines World 2021 (France)
- Vaccine Research & Development - Euro Vaccines 2021 (Spain)
- Vaccine Safety & Efficacy - Vaccines World 2021 (France)
- Vaccine Safety and Efficacy - Vaccines R&D 2021 (Netherlands)
- Vaccines - Vaccines World 2021 (France)
- Vaccines Against Infectious Diseases - Vaccines World 2021 (France)
- Vaccines against Viral and Bacterial Diseases - Euro Vaccines 2021 (Spain)
- Vaccines Business Development - Euro Vaccines 2021 (Spain)
- Vaccines for Older Adults - Euro Vaccines 2021 (Spain)
- Vaccines for Pregnant Women - Vaccines World 2021 (France)
- Vaccines for Respiratory Diseases - Euro Vaccines 2021 (Spain)
- Vaccines for Unconventional Diseases - Vaccines World 2021 (France)
- Vaccines for Vector-borne Diseases - Euro Vaccines 2021 (Spain)
- Vaccines Manufacturing Technologies - Vaccines World 2021 (France)
- Vaccines Research and Clinical Trails - Vaccines World 2021 (France)
- Vaccines safety & Efficacy - Euro Vaccines 2021 (Spain)
- Veterinary Vaccines - Euro Vaccines 2021 (Spain)
- Veterinary Vaccines and Animal Health - Vaccines R&D 2021 (Netherlands)
- Viral Vaccines and Bacterial Vaccines - Vaccines R&D 2021 (Netherlands)
- Virology and Antiviral Drugs - Vaccines R&D 2021 (Netherlands)
- Zika Virus Vaccines - Vaccines World 2021 (France)